Longevity Startups

GlycoX develops a food ingredient derived from a native plant oil that aims to reduce post-meal blood-sugar spikes and support metabolic health. It is positioned as a preventive, food-based approach to glucose control and longevity for everyday consumers.

2 investors

Habitat Health operates PACE (Program of All-Inclusive Care for the Elderly) centers offering medical care, social services, home care, and transportation for adults age 55 and older. It serves seniors in Sacramento and South Los Angeles, California.

2 investors

Holo offers a health membership combining advanced lab testing of 110+ biomarkers, wearable data, clinician reports, and an AI health assistant to help individuals track their health and biological age over time. It operates through partner labs across Spain and Andorra.

2 investors

Imel Biotherapeutics is a biotech company focused on mitochondrial biology, targeting mitochondrial dysfunction implicated in aging, cellular senescence, and T cell exhaustion in the elderly population.

2 investors

Independa operates Health Hub, a HIPAA-compliant health and wellness platform for seniors that delivers telehealth, video calling, family communication, games, and fitness tools across TVs, tablets, computers, and phones. It serves older adults and their families and caregivers, and works with senior living, home care, PACE, and health organizations.

2 investors

InnovAge operates a Program of All-Inclusive Care for the Elderly (PACE), providing integrated healthcare and social services to seniors. The organization delivers coordinated care designed to help elderly individuals remain independent and in their communities.

2 investors

Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.

2 investors

iollo develops Quinn, an AI system for computational R&D in life sciences that automates data coding, analysis, and interpretation from target discovery through clinical trials. It also offers a consumer metabolomics test panel that measures markers related to energy production, inflammation, and cellular aging.

2 investors

Kind Biotechnology develops the ION platform, which uses artificial genomic constructs to grow interconnected peripheral organs for xenotransplantation. The company aims to address organ scarcity in transplant medicine to treat age-related organ failure and extend healthy human lifespan.

2 investors

L-Nutra develops fasting-mimicking technology and nutrition-based products designed to slow biological aging and treat age-related diseases. The company focuses on translating longevity research into consumer health interventions.

2 investors

Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease. The company's approach aims to restore cellular balance by enhancing the body's natural ability to clear toxic proteins and dysfunctional organelles.

2 investors

Life AI Biohub provides an infrastructure layer for human health that combines AI, biotech, and human participation, offering access to real-world health trajectory data from over 550,000 people. It connects phenotype, intervention, and outcome data—genetic markers, biomarkers, and lifestyle factors—to identify which interventions work for which patient phenotypes.

2 investors

Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.

2 investors

Longeveron is a clinical-stage biotechnology company developing allogeneic cellular therapies for life-threatening conditions affecting children and the elderly. Its investigational candidate is being evaluated for indications including Hypoplastic Left Heart Syndrome, Pediatric Dilated Cardiomyopathy, Alzheimer's Disease, and age-related frailty.

2 investors

A clinical software platform that aggregates patient data from wearables, labs, and clinical inputs to generate medical summaries and support care decision-making. The system provides tools for practitioners to review, edit, and export patient information alongside AI-generated insights.

2 investors

A venture capital firm focused on the longevity sector, backing founder-driven companies working on extending human healthy lifespan. It runs investment funds and an accelerator for longevity startups, and has backed some of the first longevity companies to reach IPO and bring drug candidates to market.

2 investors

Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring. Its liquid biopsy and tissue tests serve oncology patients and clinicians across multiple solid tumors and hematological cancers, available internationally and in the USA.

2 investors

Macomics is a drug discovery company developing therapies that target macrophage activity for diseases with limited or ineffective treatment options. It operates in the biotechnology and therapeutics sector.

2 investors

Magnitude Biosciences provides a high-powered imaging assay that measures mitochondrial health and age-related morphological changes using C. elegans muscle tissue as a model system. The service helps researchers and pharmaceutical companies assess whether test compounds protect against age-associated mitochondrial degradation.

2 investors

MeetCaregivers is a technology-enabled in-home senior care company that matches seniors with compatible caregivers and provides tools to coordinate and track care for families, health providers, and payers. It also offers augmented staffing services to hospitals and senior care communities and connects members to senior care products, operating in the US including Massachusetts and Florida.

2 investors

Modern Age is a longevity-focused health clinic that provides proactive aging interventions to slow down the aging process. The clinic serves individuals seeking preventive health solutions in the longevity and healthcare space.

2 investors

Moira Club is a membership-based concierge wellness platform for people aging at home, pairing a support team with personalized vitality and care plans covering longevity, strength, and daily health coordination. It handles tasks such as appointment reminders, prescription refills, meal coordination, and check-ins to help members live independently.

2 investors

Neurogene develops gene therapy treatments for rare neurological diseases. The company aims to make severe genetic neurological conditions treatable for patients and families impacted by these conditions.

2 investors

Neuroglee provides remote dementia and memory care through a care team of navigators, clinicians, social workers, and pharmacists who coordinate treatment, offer 24/7 support, and connect patients and caregivers with community resources. It also helps manage other long-term conditions and serious illnesses for patients and their families at home.

2 investors